View Author
expression leukemia patient mutation myeloid leukemia cluster myeloid evi 1 cebpa analysis blood protein figure evi 1 expression group table methylation sample survival pml-rar gene expression level abnormality pml-rar ␣ number promoter probe cytogenetic value erasmus mc signature study factor manuscript erasmu 1-evi fusion author cancer retinoic prognostic cohort cebpa mutations marrow cebpasil mds 1-evi marker karyotype id 1 promoter transcription domain notch dna methylation signi nih-pa treatment sequence probe sets outcome g-csf aml patients control promyelocytic retinoic acid analyses differentiation volume receptor promyelocytic leukemia j clin oncol correlation library subtype transcript mds 1-evi expression triad cebpamut bone marrow method npm 1 mutations
10 Most Recent Publications
|
Risk stratification of intermediate-risk acute myeloid leukemia: Integrative analysis of a multitude of gene mutation and gene expression markers
(Article)
Rockova, V. Abbas, S. Wouters, B.J. Erpelinck, C.A.J. Beverloo, H.B. Delwel, H.R. Putten, W.L.J. van Löwenberg, B. Valk, P.J.M. |
2011-07-28
|
|
Mutant Wilms tumor 1 (WT1) mRNA with premature termination codons in acute myeloid leukemia (AML) is sensitive to nonsense-mediated RNA decay (NMD)
(Article)
Abbas, S. Erpelinck, C.A.J. Goudswaard, C.S. Löwenberg, B. Valk, P.J.M. |
2010-03-01
|
|
DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
(Article)
Figueroa, M.E. Lugthart, S. Campagne, F. Mazumdar, M. Greally, J.M. Valk, P.J.M. Löwenberg, B. Delwel, H.R. Melnick, A. Li, Y. Erpelinck, C.A.J. Deng, X. Christos, P.J. Schifano, E. Booth, J. Putten, W.L.J. van Skrabanek, L. |
2010-01-19
|
|
Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
(Article)
Wouters, B.J. Löwenberg, B. Erpelinck, C.A.J. Putten, W.L.J. van Valk, P.J.M. Delwel, H.R. |
2009-03-26
|
|
Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features
(Article)
Figueroa, M.E. Wouters, B.J. Valk, P.J.M. Melnick, A. Delwel, H.R. Skrabanek, L. Glass, J. Li, Y. Erpelinck, C.A.J. Langerak, A.W. Löwenberg, B. Fazzari, M. Greally, J.M. |
2009-03-19
|
|
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling
(Article)
Verhaak, R.G.W. Wouters, B.J. Erpelinck, C.A.J. Abbas, S. Beverloo, H.B. Lugthart, S. Löwenberg, B. Delwel, H.R. Valk, P.J.M. |
2009-01-01
|
|
High EVI1 levels predict adverse outcome in acute myeloid leukemia: Prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated
(Article)
Lugthart, S. Drunen, E. van Norden, Y. van Hoven, A. van Erpelinck, C.A.J. Valk, P.J.M. Beverloo, H.B. Löwenberg, B. Delwel, H.R. |
2008-04-15
|
|
Gene transactivation without direct DNAbinding defines a novel gain-of-function for PML-RARα
(Article)
Wageningen, S. van Breems-de Ridder, M.C. Nigten, J. Nikoloski, G. Erpelinck, C.A.J. Löwenberg, B. Witte, T. de Tenen, D.G. Reijden, B.A. van der Jansen, J.H. |
2008-02-12
|
|
Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1
(Article)
Wouters, B.J. Jordà, M.A. Hetherington, C.J. Verhaak, R.G.W. Valk, P.J.M. Löwenberg, B. Tenen, D.G. Pear, W.S. Delwel, H.R. Keeshan, K. Louwers, I. Erpelinck, C.A.J. Tielemans, D. Langerak, A.W. He, Y. Yashiro-Ohtani, Y. Zhang, P. |
2007-11-15
|
|
Prognostically useful gene-expression profiles in acute myeloid leukemia
(Article)
Valk, P.J.M. Delwel, H.R. Khosrovani, S. Beijen, M.A. Erpelinck, C.A.J. Boer, J.M. Beverloo, H.B. Moorhouse, M.J. Spek, P.J. van der Löwenberg, B. Verhaak, R.G.W. |
2004-01-01
|
